Clinical Ink, a pharma-focused mobile clinical trial data collection company, has raised $4.3 million. FCA Venture partners led the round, with additional funding from 10 undisclosed angel investors.
Cambridge, Massachusetts-based Clinical Research IO, which developed an electronic platform for researchers to quickly capture data during clinical trials, has raised $1.6 million in seed funding in a ...
A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...
The clinical trial industry is at a critical juncture where traditional methods are proving insufficient for managing today’s ...
Transforming Clinical Research: assisTek's Innovative New Platform Raises the Bar for Data Collection and Patient Impact DOYLESTOWN, PA / ACCESSWIRE / March 26, 2024 / assisTek, a leading innovator in ...
Solutions Market Overview:The global electronic clinical outcome assessment (eCOA) solutions market is expected to grow at a ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In the last decade, the volume of clinical trial data has surged, presenting unprecedented ...
Discover how remote assessments, wearables, and digital technologies can decentralize data collection, reduce patient burden, and enable trials to reach more diverse and representative populations.
Clinical Trials Arena on MSN

AI takes charge of data, but challenges linger

At CDMI Europe 2025, experts agreed that AI is the key technology to improve efficiencies in clinical trial data management.
This Collection seeks to advance the discussion on noninvasive biomarkers by exploring their applications and implications across different data landscapes, namely real-world data (RWD) and clinical ...
This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Clinical trials represent a significant ...